Skip to main content
NORTHEAST PHARMACEUTICAL GROUP CO.,LTD logo

NORTHEAST PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 000597 ISIN · CNE0000009G0 LEI · 300300HX6JTMOEENF158 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,606 across all filing types
Latest filing 2024-03-31 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 000597

About NORTHEAST PHARMACEUTICAL GROUP CO.,LTD

https://www.nepharm.com.cn

Northeast Pharmaceutical Group Co., Ltd. (NEPG) specializes in the research, development, manufacture, and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a large-scale integrated pharmaceutical enterprise with a diverse product portfolio encompassing vitamins, antibiotics, cardiovascular agents, and digestive system medications. NEPG is recognized as a global leader in the production of Vitamin C and Vitamin B1, alongside significant output in caffeine and fosfomycin. Its manufacturing facilities adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications. The company serves a broad international market, exporting products to numerous countries while maintaining a strong domestic presence. NEPG focuses on technological innovation and industrial scaling to provide high-quality chemical raw materials and pharmaceutical preparations for global healthcare needs.

Recent filings

Filing Released Lang Actions
2023年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the "2023 Annual Financial Settlement Report" of Northeast Pharmaceutical Group Co., Ltd. It contains detailed financial data for the full year 2023, including revenue, profit, cost, asset-liability structure, and cash flow analysis. The report is prepared according to the latest enterprise accounting standards and covers comprehensive financial performance and business analysis for the entire fiscal year. The length of the document (4495 characters) and the detailed financial tables indicate it is the actual financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-03-31 Chinese
关于公司2023年度利润分配预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the company's 2023 annual profit distribution plan, including details on proposed cash dividends, board and supervisory committee approvals, and compliance with relevant laws and regulations. It does not contain full financial statements or comprehensive financial performance data but rather focuses on the dividend proposal and related approvals. The document length is short (1777 characters) and it is clearly an announcement of a profit distribution plan, which aligns with a Notice of Dividend Amount filing rather than a full Annual Report or Earnings Release. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2024-03-31 Chinese
关于公司常务副总经理辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's Executive Vice General Manager. It includes details about the resignation, the individual's shareholding, and compliance with relevant laws. There is no financial data, no mention of a report or meeting, and it concerns a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2024-03-29 Chinese
第九届董事独立董事2024年第二次专门会议审核意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from the independent directors of the company regarding specific agenda items to be submitted to the board of directors. It references compliance with stock exchange listing rules and company bylaws, and discusses approval of guarantees and related party transactions. The content is focused on board-level review and approval processes rather than financial results, audit opinions, or shareholder voting outcomes. It is not a full annual or interim report, nor an earnings release or regulatory filing. The document fits best under Board/Management Information (MANG) as it concerns board meeting matters and independent directors' opinions on company governance issues.
2024-03-29 Chinese
关于公司及子公司2024年度金融机构授信总额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the total credit limit for financing that the company and its subsidiaries plan to apply for in the 2024 fiscal year. It includes details about the credit amounts, types of financing, and guarantees, as well as references to board and supervisory committee meeting resolutions. The document is relatively short (1477 characters) and serves as a formal disclosure of financing plans and authorization requests to shareholders. It does not contain actual financial statements or detailed financial performance data, nor is it a transcript, report, or presentation. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2024-03-29 Chinese
董事会对独立董事独立性评估的专项意见
Board/Management Information Classification · 95% confidence The document is a board announcement regarding the assessment of the independence of the company's independent directors for the year 2023. It references regulatory requirements and confirms the independence of specific directors. There is no financial data, no report attached or referenced as being published, and no mention of voting results or management changes beyond independence assessment. This fits the category of Board/Management Information (MANG), as it relates to board matters and director independence evaluation.
2024-03-29 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.